Interacting Drugs |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Carbonic Anhydrase Inhibitors |
Security Level |
|
Mechanism |
Carbonic Anhydrase Inhibitors: May enhance the adverse/toxic effect of Anticonvulsants (Barbiturate). Specifically, osteomalacia and rickets. Exceptions: Brinzolamide; Dorzolamide. |
Management |
Monitor therapy |
Hyoscyamine, atropine, scopolamine, and phenobarbital vs Carbonic Anhydrase Inhibitors
Post Review about Hyoscyamine, atropine, scopolamine, and phenobarbital vs Carbonic Anhydrase Inhibitors Click here to cancel reply.
Other Interactions of Hyoscyamine, atropine, scopolamine, and phenobarbital
Other Interactions of Carbonic Anhydrase Inhibitors
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.